[go: up one dir, main page]

EP1115702A4 - Durch stickstoff und schwefel substituierte alicyklische verbindungen und verfahren zu ihrer herstellung - Google Patents

Durch stickstoff und schwefel substituierte alicyklische verbindungen und verfahren zu ihrer herstellung

Info

Publication number
EP1115702A4
EP1115702A4 EP99932200A EP99932200A EP1115702A4 EP 1115702 A4 EP1115702 A4 EP 1115702A4 EP 99932200 A EP99932200 A EP 99932200A EP 99932200 A EP99932200 A EP 99932200A EP 1115702 A4 EP1115702 A4 EP 1115702A4
Authority
EP
European Patent Office
Prior art keywords
synthesis
including methods
substituted nitrogen
alicyclic compounds
sulfur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99932200A
Other languages
English (en)
French (fr)
Other versions
EP1115702A1 (de
Inventor
Mukund Shankar Chorghade
Mukund Keshao Gurjar
Radha Krishna Palakodety
Sista Venkata Sai Lalitha
Kashinath Sadalapure
Susanta Sekhar Adhikari
Andappan Murugaiah S Murugaiah
Batchu Venkateswara Rao
Arindam Talukdar
Aminul Islam
Chittineni Hariprasad
Alla Venkata Rana Rao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of EP1115702A1 publication Critical patent/EP1115702A1/de
Publication of EP1115702A4 publication Critical patent/EP1115702A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
EP99932200A 1998-07-03 1999-07-02 Durch stickstoff und schwefel substituierte alicyklische verbindungen und verfahren zu ihrer herstellung Withdrawn EP1115702A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9171098P 1998-07-03 1998-07-03
US91710P 1998-07-03
PCT/US1999/015050 WO2000001670A1 (en) 1998-07-03 1999-07-02 Substituted nitrogen and sulfur alicyclic compounds, including methods for synthesis thereof

Publications (2)

Publication Number Publication Date
EP1115702A1 EP1115702A1 (de) 2001-07-18
EP1115702A4 true EP1115702A4 (de) 2002-04-17

Family

ID=22229271

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99932200A Withdrawn EP1115702A4 (de) 1998-07-03 1999-07-02 Durch stickstoff und schwefel substituierte alicyklische verbindungen und verfahren zu ihrer herstellung

Country Status (6)

Country Link
EP (1) EP1115702A4 (de)
JP (1) JP2002519410A (de)
AU (1) AU4856199A (de)
CA (1) CA2356841A1 (de)
MX (1) MXPA01000233A (de)
WO (1) WO2000001670A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003097622A2 (en) 2002-05-15 2003-11-27 Genzyme Corporation Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
US7618959B2 (en) 2002-11-05 2009-11-17 Smithklinebeecham Corp Antibacterial agents

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001430A1 (en) * 1992-07-13 1994-01-20 Cytomed, Inc. 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5681966A (en) * 1994-06-27 1997-10-28 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543531A (en) * 1987-06-16 1996-08-06 Sandoz Ltd. Thiophen compounds and their preparation
WO1996020189A1 (fr) * 1994-12-28 1996-07-04 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Procede de production d'un derive d'acide carboxylique

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994001430A1 (en) * 1992-07-13 1994-01-20 Cytomed, Inc. 2,5-diaryl tetrahydro-thiophenes, -furans and analogs for the treatment of inflammatory and immune disorders
US5358938A (en) * 1992-07-13 1994-10-25 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5434151A (en) * 1992-08-24 1995-07-18 Cytomed, Inc. Compounds and methods for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5681966A (en) * 1994-06-27 1997-10-28 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders
US5703093A (en) * 1995-05-31 1997-12-30 Cytomed, Inc. Compounds and methods for the treatment of cardiovascular, inflammatory and immune disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0001670A1 *

Also Published As

Publication number Publication date
MXPA01000233A (es) 2003-02-10
EP1115702A1 (de) 2001-07-18
WO2000001670A1 (en) 2000-01-13
JP2002519410A (ja) 2002-07-02
AU4856199A (en) 2000-01-24
CA2356841A1 (en) 2000-01-13

Similar Documents

Publication Publication Date Title
IL157478A0 (en) Method for the synthesis of 2', 3'-didehydronucleosides
EG24350A (en) Prilling method
HK1040076A1 (zh) 作為整聯蛋白抑制劑的喹嗪酮
GB2336843B (en) Carboxyl-containing alicyclic compounds and a process for preparing the same
SG80044A1 (en) Ammonia analyzer
GB0013459D0 (en) Track tensioning apparatus
EP1118622A4 (de) Neue antikörper, arzneistoffe die diese enthalten und methoden zum screening von verbindungen unter verwendung dieser antikörper
GB2345042B (en) Track tension system
EP1207150A4 (de) Langkettige n-epsilon acyllysin-kristalle, verfahren zu ihrer herstellung und kosmetika, die diese enthalten
GB2355714B (en) Ammonium 3,5-diaminopicrate
HK1024175A1 (en) Plasters for percutaneous absorption
IT1304860B1 (it) Chiusura riapribile per lattine
EP1115702A4 (de) Durch stickstoff und schwefel substituierte alicyklische verbindungen und verfahren zu ihrer herstellung
PL343734A1 (en) Process for making 1,3-disubstituted-4-oxocyclic ureas
EP1094805A4 (de) Alicyclische verbindungen mit substituiertem sauerstoffatom, sowie deren bereitungsverfahren
HUP0103260A3 (en) Peptidomimetic compounds and process for their synthesis
AU3060099A (en) Catalyst for the synthesis of ammonia from hydrogen and nitrogen
PL343733A1 (en) Process for making 1,3-disubstituted-4-oxocyclic ureas
HUP0103358A3 (en) N-substituted azabicycloheptane derivatives, production and use thereof
AU4702800A (en) Tie down strap
PL330139A1 (en) Wind clasp for roofings
HUP0100965A3 (en) Method for executing track skipping
HUP0203248A3 (en) Substituted ureas
TW367751U (en) Shoulder strap used for single or double shoulder carried
AU4638197A (en) Process for the urea synthesis from ammonia and carbon dioxide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010131

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 07D 333/32 A, 7A 61K 31/38 B

A4 Supplementary search report drawn up and despatched

Effective date: 20020304

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20040504

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040203